AEON Biopharma, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
AEON Biopharma, Inc. (AEON) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $297.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-30
- AEON Biopharma, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $297.00K, a 79.45% decline from fiscal 2024.
- AEON Biopharma, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $1.45M, a 59.96% decline from fiscal 2023.
- AEON Biopharma, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $3.61M, a 4.80% decline from fiscal 2022.
- AEON Biopharma, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $3.79M.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $297.00K 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.45M 10-K · filed 2026-03-30 |
| 2023-12-31 | $3.61M 10-K · filed 2025-03-24 |
| 2022-12-31 | $3.79M 10-K/A · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |